Abstract:The synaptic vesicle glycoprotein 2C (SV2C) works in concert with the vesicular monoamine transporter 2 (VMAT2) to regulate vesicular dopamine dynamics. Because of the leaky nature of synaptic vesicles, substrate (e.g. FFN206, dopamine, MPP+) will leak out over time, decreasing the vesicular content. Blocking VMAT2 through inhibition results in an increase in the amount of substrate lost over time because of a loss of reuptake capabilities. A lack of SV2C expression similarly results in an increase in the amount of substrate lost over time. The cumulative loss of substrate over time is exacerbated in conditions with no SV2C expression and VMAT2 inhibition. Dopaminergic neurons of the substantia nigra exist in a persistent state of vulnerability resulting from high baseline oxidative stress, high‐energy demand, and broad unmyelinated axonal arborisations. Impairments in the storage of dopamine compound this stress because of cytosolic reactions that transform the vital neurotransmitter into an endogenous neurotoxicant, and this toxicity is thought to contribute to the dopamine neuron degeneration that occurs Parkinson's disease. We have previously identified synaptic vesicle glycoprotein 2C (SV2C) as a modifier of vesicular dopamine function, demonstrating that genetic ablation of SV2C in mice results in decreased dopamine content and evoked dopamine release in the striatum. Here, we adapted a previously published in vitro assay utilising false fluorescent neurotransmitter 206 (FFN206) to visualise how SV2C regulates vesicular dopamine dynamics and determined that SV2C promotes the uptake and retention of FFN206 within vesicles. In addition, we present data indicating that SV2C enhances the retention of dopamine in the vesicular compartment with radiolabelled dopamine in vesicles isolated from immortalised cells and from mouse brain. Further, we demonstrate that SV2C enhances the ability of vesicles to store the neurotoxicant 1‐methyl‐4‐phenylpyridinium (MPP+) and that genetic ablation of SV2C results in enhanced 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced vulnerability in mice. Together, these findings suggest that SV2C functions to enhance vesicular storage of dopamine and neurotoxicants and helps maintain the integrity of dopaminergic neurons.

Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease

Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity

Synaptic vesicle 2C and its synaptic-related function.

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson's Disease.

The Synaptic Vesicle Protein 2a Interacts with Key Pathogenic Factors in Alzheimer’s Disease: Implications for Treatment

VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates

Synaptic Vesicle-Related Proteins and Ubiquilin 2 in Cortical Synaptosomes Mediate Cognitive Impairment in Vascular Dementia Rats

Synaptic loss and its association with symptom severity in Parkinson’s disease

Α-Synuclein Induces Deficiency in Clathrin-Mediated Endocytosis Through Inhibiting Synaptojanin1 Expression

Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation

Synaptic Vesicle Depletion Correlates With Attenuated Synaptic Responses To Prolonged Repetitive Stimulation In Mice Lacking Alpha-Synuclein

Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy

Synaptic Loss in Spinocerebellar Ataxia Type 3 Revealed by SV2A Positron Emission Tomography

Alpha Synuclein and Vesicular Monoamine Transporter2 Expression Modulate the Vulnerability of Nigral Neurons to Dopaminergic Neurotoxicants

Crosstalk Between Presynaptic Trafficking and Autophagy in Parkinson's Disease

Synj1 Haploinsufficiency Causes Dopamine Neuron Vulnerability and Alpha-Synuclein Accumulation in Mice

Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration.

Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.

The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition

Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China

Presynaptic Terminal Integrity is Associated with Glucose Metabolism in Parkinson’s Disease